Strategic Signals Weekly Archive
Licensing deals, strategic reviews, and financing events from regulatory filings. Part of the RxDataLab platform — clinical trials, SEC filings, and hedge fund positioning, linked by company.
Strategic Signals Weekly: March 09 – March 16, 2026
18 biotech strategic signals: 1 licensing deals, 1 strategic reviews, 15 financing events.
Strategic Signals Weekly: March 02 – March 09, 2026
20 biotech strategic signals: 4 licensing deals, 1 strategic reviews, 14 financing events.
Strategic Signals Weekly: February 23 – March 02, 2026
18 biotech strategic signals: 1 licensing deals, 2 strategic reviews, 14 financing events.
Strategic Signals Weekly: February 16 – February 23, 2026
16 biotech strategic signals: 1 licensing deals, 1 strategic reviews, 13 financing events.
Strategic Signals Weekly: February 08 – February 15, 2026
7 biotech strategic signals: 0 licensing deals, 1 strategic reviews, 6 financing events.
Strategic Signals Weekly: February 01 – February 08, 2026
12 biotech strategic signals: 1 licensing deals, 0 strategic reviews, 11 financing events.
Strategic Signals Weekly: January 24 – January 31, 2026
20 biotech strategic signals: 2 licensing deals, 1 strategic reviews, 17 financing events.